# John F. Thompson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-f-thompson-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 116,716 |
| Field | Cutaneous Melanoma Detection and Management |
| h-index | 136 |
| i10-index | 880 |
| Last Known Institution | The University of Sydney |
| OpenAlex ID | https://openalex.org/A5035263718 |
| ORCID iD | https://orcid.org/0000-0002-2816-2496 |
| Works | 1,949 |

## Researcher papers

- [Final Version of 2009 AJCC Melanoma Staging and Classification](https://scholariq.org/papers/final-version-of-2009-ajcc-melanoma-staging-and-classification/)
- [Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma](https://scholariq.org/papers/final-version-of-the-american-joint-committee-on-cancer-staging-system-for/)
- [Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System](https://scholariq.org/papers/prognostic-factors-analysis-of-17-600-melanoma-patients-validation-of-the/)
- [Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma](https://scholariq.org/papers/completion-dissection-or-observation-for-sentinel-node-metastasis-in-melanoma/)
- [Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma](https://scholariq.org/papers/validation-of-the-accuracy-of-intraoperative-lymphatic-mapping-and-sentinel/)
- [A new American Joint Committee on Cancer staging system for cutaneous melanoma](https://scholariq.org/papers/a-new-american-joint-committee-on-cancer-staging-system-for-cutaneous-melanoma/)
- [Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases](https://scholariq.org/papers/multivariate-analysis-of-prognostic-factors-among-2-313-patients-with-stage-iii/)
- [Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome](https://scholariq.org/papers/outcomes-from-a-12-week-open-label-multicenter-clinical-trial-of-teduglutide-in/)
- [Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I)](https://scholariq.org/papers/metastasectomy-for-distant-metastatic-melanoma-analysis-of-data-from-the-first/)

## Researcher topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [The University of Sydney](https://scholariq.org/institutions/the-university-of-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
